Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -237.93% is 54% below its 4-year average of -154.48%, around the middle of its 4-year range (-458.31%–-22.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.00% below its 12-month average of -233.28%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -237.93%.
RETURN ON INVESTED CAPITAL (ROIC)
-237.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-233.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-161.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.00%
CURRENT VS 3Y AVG
-47.13%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.88%
median of 495 covered companies
CURRENT VS SECTOR MEDIAN
-723.87%
vs the sector median at left
bioAffinity Technologies, Inc.
Market Cap
$2.75M
Return on Invested Capital (ROIC)
-237.93%
TTM Avg
-233.28%
3Y Avg
-161.72%
5Y Avg
N/A
Market Cap
$2.64M
Return on Invested Capital (ROIC)
-476.39%
TTM Avg
-313.80%
3Y Avg
-198.00%
5Y Avg
-161.97%
Market Cap
$2.52M
Return on Invested Capital (ROIC)
-286.46%
TTM Avg
-159.21%
3Y Avg
-198.72%
5Y Avg
-198.72%
Market Cap
$3.04M
Return on Invested Capital (ROIC)
-464.86%
TTM Avg
-2260.77%
3Y Avg
-1213.54%
5Y Avg
-842.71%
Market Cap
$3.07M
Return on Invested Capital (ROIC)
-75.31%
TTM Avg
-107.77%
3Y Avg
-224.28%
5Y Avg
-195.58%
Market Cap
$2.38M
Return on Invested Capital (ROIC)
-59.10%
TTM Avg
-35.54%
3Y Avg
-33.20%
5Y Avg
-24.47%
Market Cap
$2.22M
Return on Invested Capital (ROIC)
-985.20%
TTM Avg
-494.63%
3Y Avg
-376.51%
5Y Avg
-304.92%
Market Cap
$2.32M
Return on Invested Capital (ROIC)
-71.90%
TTM Avg
-86.03%
3Y Avg
-72.74%
5Y Avg
-64.31%
Market Cap
$3.34M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-160.18%
3Y Avg
-147.91%
5Y Avg
-122.63%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.75M | -237.93% | -233.28% | -161.72% | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -476.39% | -313.80% | -198.00% | -161.97% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | -286.46% | -159.21% | -198.72% | -198.72% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -464.86% | -2260.77% | -1213.54% | -842.71% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | -75.31% | -107.77% | -224.28% | -195.58% |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | -59.10% | -35.54% | -33.20% | -24.47% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.22M | -985.20% | -494.63% | -376.51% | -304.92% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -71.90% | -86.03% | -72.74% | -64.31% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.34M | -133.29% | -160.18% | -147.91% | -122.63% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | -284.81% | -319.42% | -246.02% | -246.02% |
ROIC
-237.9%
ROE
-402.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -237.93% |
| 2026-03-31 | -229.23% |
| 2025-12-31 | -129.57% |
| 2025-09-30 | -111.36% |
| 2025-06-30 | -458.31% |
| 2025-03-31 | -430.80% |
| 2024-12-31 | -250.07% |
| 2024-09-30 | -192.92% |
| 2024-06-30 | -200.22% |
| 2024-03-31 | -133.08% |
| 2023-12-31 | -133.47% |
| 2023-09-30 | -88.14% |
| 2023-06-30 | -72.92% |
| 2023-03-31 | -49.22% |
| 2022-12-31 | -35.51% |
| 2022-09-30 | -22.72% |
